Ivermectin and its antiviral action against SARS-CoV-2: From in vitro effect to clinical practice
Keywords:
ivermectin, antiviral action, SARS-CoV-2Abstract
Introduction: Since the end of 2019, the world is being affected by a new pandemic caused by SARS-CoV-2, with considerable numbers of deaths in several countries, including Peru. One of the drugs used against this infection is ivermectin, due to its potential antiviral effect. Recently, after conducting in vitro studies, several researchers have argued that the inhibitory action on nuclear transport of ivermectin could be effective against SARS-CoV-2 in humans.
Objective: To collect information about the antiviral action of ivermectin against SARS-CoV-2 and to analyze its use in clinical practice.
Methods: The search strategy was designed based on the terms of the research topic. Descriptors in health sciences (DsCS) were searched in BIREME and connectors were used in PubMed. Only primary studies within the years 2019 and 2020 were included.
Conclusions: Various clinical trials are being carried out with ivermectin, due to its potential antiviral effect. However, they are in different assessment and execution stages, a reason why it is appropriate to wait for new outcomes of this research in the following months. Unfortunately, the few published scientific studies lack a strong methodology, a reason why their findings should not be considered for public health practice.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:- Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
- Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
- Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).
